Contact this trialFirst, we need to learn more about you.
Altropane Imaging for Parkinson's Disease
Recruiting1 awardPhase 2
Omaha, Nebraska
This trial is testing if a lower dose of Altropane (5 millicuries) can be used for brain imaging in patients suspected of having Parkinson's disease. Altropane helps doctors see specific areas of the brain more clearly on scans. The goal is to determine if a smaller amount can still provide clear images. Altropane is a special substance used in brain imaging to help visualize specific areas, particularly in diagnosing Parkinson's disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.